n.a. (ASTX)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
DACOGEN(R) Approved In The European Union For The Treatment Of Acute Myeloid Leukemia

DACOGEN(R) Approved In The European Union For The Treatment Of Acute Myeloid Leukemia

New Treatment Offers Clinically Significant Benefit for Patients

3 Stocks Under $5 Ripping Higher

3 Stocks Under $5 Ripping Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Astex Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript

Astex Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript

Astex Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

There isn't a day that goes by on Wall Street when certain stocks trading near or under $10 a share don't experience massive spikes higher.

Astex Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Astex Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Astex Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript

5 Stocks Under $5 Making Big Moves

5 Stocks Under $5 Making Big Moves

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Astex Pharmaceuticals To Present At AACR Annual Meeting

Astex Pharmaceuticals To Present At AACR Annual Meeting

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the acceptance of fourteen abstracts for ...

Astex Pharmaceuticals Announces March 27th Analyst And Investor Day Agenda

Astex Pharmaceuticals Announces March 27th Analyst And Investor Day Agenda

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the Agenda for its Annual Analyst and Investor Day...

Astex Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Astex Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Astex Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Astex Pharmaceuticals Reports 2011 Fourth Quarter And Year-End Financial Results

Astex Pharmaceuticals Reports 2011 Fourth Quarter And Year-End Financial Results

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), today reported financial results for the fourth quarter and year ended December 31, 2011.

Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash

Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash

Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.

Astex Pharmaceuticals To Announce 2011 Fourth Quarter And Year-End Financial Results On March 5, 2012

Astex Pharmaceuticals To Announce 2011 Fourth Quarter And Year-End Financial Results On March 5, 2012

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that it will release its 2011 fourth quarter and...

These Drugs Stocks Will Win FDA Approval

These Drugs Stocks Will Win FDA Approval

Contestants in TheStreet's FDA Drug-Approval Contest forecast their winners and losers.

Astex Pharmaceuticals To Host Annual Analyst And Investor Day On March 27, 2012

Astex Pharmaceuticals To Host Annual Analyst And Investor Day On March 27, 2012

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced its Annual Analyst and Investor Day will take place...

Astex Pharmaceuticals Announces Presentations At Upcoming Conferences

Astex Pharmaceuticals Announces Presentations At Upcoming Conferences

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.

Astex Announces Early Transfer Of Epigenetics Project To GSK

Astex Announces Early Transfer Of Epigenetics Project To GSK

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) today announced that the multi-year collaboration to discover cancer therapeutics based on epigenetic targets entered into by SuperGen, Inc.

Astex Pharmaceuticals To Present At Biotech Showcase On January 9th

Astex Pharmaceuticals To Present At Biotech Showcase On January 9th

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel therapeutics, today announced that James S.

Astex Announces FDA ODAC Meeting Of SNDA Application For Dacogen In Treatment Of Elderly AML

Astex Announces FDA ODAC Meeting Of SNDA Application For Dacogen In Treatment Of Elderly AML

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), today announced the pre-publication notice of the Food and Drug Administration (FDA), Oncologic Drugs Advisory Committee (ODAC) Meeting to discuss the supplemental new drug...